Delcath Systems Net Receivables Over Time
| DCTH Stock | USD 10.50 0.74 7.58% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Delcath Systems Performance and Delcath Systems Correlation. Delcath |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Delcath Systems. If investors know Delcath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 0.505 | Quarterly Revenue Growth 14.689 | Return On Assets (0.82) | Return On Equity (4.79) |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Delcath Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Delcath Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Delcath Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Receivables Analysis
Compare Delcath Systems and related stocks such as Neuropace, SurModics, and ProSomnus, Common Stock Net Receivables Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NPCE | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 6 M | 8.4 M | 7.1 M | 7.5 M | 12.3 M | 9.1 M |
| SRDX | 1.1 M | 5.1 M | 5.3 M | 4.8 M | 7.5 M | 6.9 M | 7.2 M | 8.9 M | 17.2 M | 13.8 M | 22.9 M | 24.2 M | 23.9 M | 23.2 M | 11.8 M |
| CVRX | 719 K | 719 K | 719 K | 719 K | 719 K | 719 K | 719 K | 719 K | 719 K | 719 K | 1.3 M | 2.6 M | 5.5 M | 7.6 M | 3.9 M |
| LIVN | 100 K | 29.3 M | 39.5 M | 50.7 M | 50.6 M | 272.4 M | 275.7 M | 282.1 M | 256.1 M | 257.8 M | 184.4 M | 185.4 M | 183.1 M | 215.1 M | 225.8 M |
| ELMD | 3.9 M | 11.2 M | 9.6 M | 6.5 M | 6.5 M | 7.8 M | 9.9 M | 11.6 M | 13.8 M | 14.1 M | 17.4 M | 21.3 M | 24.6 M | 24.1 M | 13.3 M |
| KIDS | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 2.8 M | 3.8 M | 4.1 M | 5.6 M | 9.5 M | 16.6 M | 17.5 M | 17.9 M | 24.8 M | 34.6 M | 36.3 M |
| TELA | 757 K | 757 K | 757 K | 757 K | 757 K | 757 K | 757 K | 757 K | 1.3 M | 2.8 M | 2.7 M | 4.2 M | 6.6 M | 9.7 M | 10.2 M |
| TMDX | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 1.4 M | 925 K | 3.4 M | 6.6 M | 6.9 M | 5.9 M | 27.6 M | 63.6 M | 66.8 M |
| RCEL | 3.5 M | 959.4 K | 773.1 K | 497.2 K | 650.5 K | 659.4 K | 170.2 K | 239.8 K | 3.5 M | 2.1 M | 3.5 M | 2.4 M | 5.2 M | 7.7 M | 8 M |
| CLPT | 401.6 K | 401.6 K | 445.4 K | 770.4 K | 468.9 K | 1.2 M | 865.9 K | 949.4 K | 1.2 M | 1.1 M | 1.9 M | 2.3 M | 2.7 M | 3.9 M | 4.1 M |
| SGHT | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 4.1 M | 5.4 M | 8.7 M | 15.1 M | 14.3 M | 9.1 M |
| TMCI | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 14.5 M | 18.6 M | 29.2 M | 38.1 M | 24.4 M |
| LUNG | 154.8 K | 154.8 K | 154.8 K | 154.8 K | 154.8 K | 3.4 M | 3.4 M | 3.4 M | 3.4 M | 5.9 M | 4.2 M | 6.6 M | 8.7 M | 12.1 M | 6.5 M |
| IRMD | 1.6 M | 1.6 M | 1.6 M | 2 M | 2 M | 3.9 M | 3.8 M | 3.8 M | 4.2 M | 7.3 M | 4.6 M | 5.1 M | 13.3 M | 12.2 M | 12.8 M |
| OFIX | 9.2 M | 188.1 M | 150.3 M | 75.6 M | 61.4 M | 59.8 M | 57.8 M | 63.4 M | 77.7 M | 86.8 M | 72.4 M | 78.6 M | 82.9 M | 128.1 M | 79.5 M |
| ITGR | 11 M | 103.2 M | 120.9 M | 116 M | 126.7 M | 219.1 M | 218 M | 242.5 M | 185.5 M | 216.8 M | 198.5 M | 251.8 M | 298.3 M | 326.1 M | 342.5 M |
Delcath Systems and related stocks such as Neuropace, SurModics, and ProSomnus, Common Stock Net Receivables description
My Equities
My Current Equities and Potential Positions
| Delcath Systems | DCTH |
Specialization | Health Care, Health Care Equipment & Services |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 10.5
Check out Delcath Systems Performance and Delcath Systems Correlation. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Delcath Systems technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.